Vaxcyte, Inc. (PCVX)
58.67
-1.05
(-1.76%)
USD |
NASDAQ |
Apr 28, 15:55
Vaxcyte Market Cap : 8.444B for April 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Celldex Therapeutics, Inc. | 2.217B |
| Corcept Therapeutics, Inc. | 4.968B |
| Cytokinetics, Inc. | 7.483B |
| Syndax Pharmaceuticals, Inc. | 1.859B |
| Cogent Biosciences, Inc. | 6.210B |
Market Cap Related Metrics
| PEG Ratio | -0.2186 |
| Price to Book Value | 3.144 |
| Price | 58.67 |
| Earnings Yield | -9.72% |
| PEGY Ratio | -0.2186 |